2 hours ago
The Q2 recap for nephrology spotlights key FDA decisions and top coverage from the 62nd European Renal Association Congress.
23 hours ago
Our recap of Q2 2025 in cardiology spotlights 3 FDA headlines, trial news, and new episodes of Don't Miss a Beat.
July 04, 2025
Q2 2025 saw new therapies approved for rare rheumatological conditions and exciting research out of EULAR.
July 04, 2025
According to recent research, more patients surviving heart diseases correlates directly to higher mortality rates for ischemic and chronic heart conditions.
July 04, 2025
Explore key advancements in endocrinology from Q2 2025, including FDA approvals and groundbreaking diabetes research shaping future treatments.